Numerous fusion partners of ALK have been identified (e.g., nucleophosmin (NPM)-ALK in anaplastic large cell lymphoma (ALCL) and echinoderm microtubule-associated protein-like 4 (EML4)-ALK in non-small cell lung cancer (NSCLC)). This evidence concerns the gene EML4 and non-small cell lung carcinoma.